| NCT ID | NCT04133285 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Luca Sangiorgi |
| Condition | Multiple Osteochondromas |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2013-06-28 |
| Primary Completion | 2018-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2013-06-28 with a primary completion date of 2018-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
REM is a retrospective and prospective registry, finalized for care and research purposes. It is articulated in main sections - strongly related and mutually dependent on each other - corresponding to different data domains: personal information, clinical data, genetic data, genealogical data, surgeries, etc. This approach has been developed to corroborate and integrate data from different sources evaluating several aspects of diseases and to correlate genetic background and phenotypic outcomes, in order to better investigate disease pathophysiology. Due to legal requirements, institutional directives and organizational issues, we are unable to include individuals residing outside Italy in the registry at this time. We are currently engaged in the preparation of a recruitment process for individuals residing outside Italy.
Eligibility Criteria
Inclusion Criteria: * All Multiple Osteochondromas patients, including prenatal diagnosis of Multiple Osteochondromas Exclusion Criteria: * Any condition unrelated to Multiple Osteochondromas
Contact & Investigator
Luca Sangiorgi, MD, PhD, MS
PRINCIPAL INVESTIGATOR
Istituto Ortopedico Rizzoli
Frequently Asked Questions
Who can join the NCT04133285 clinical trial?
This trial is open to participants of all sexes, studying Multiple Osteochondromas. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04133285 currently recruiting?
Yes, NCT04133285 is actively recruiting participants. Contact the research team at registri.malattierare@ior.it for enrollment information.
Where is the NCT04133285 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT04133285 clinical trial?
NCT04133285 is sponsored by Luca Sangiorgi. The principal investigator is Luca Sangiorgi, MD, PhD, MS at Istituto Ortopedico Rizzoli. The trial plans to enroll 10,000 participants.